Project Grant K01DA062727
- Federal Grant Award Summary Arizona State University (ASU) received a $684,625 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning May 1, 2026, through February 28, 2030. The award supports a multi-disciplinary research initiative investigating the association between environmental heat and drug overdose-related risks among persons who use drugs in Phoenix, Arizona. The research team, comprising investigators...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $189,000 Project Grant to The Ohio State University on March 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279). This Career Development Award supports a five-year research initiative through February 28, 2031, designed to develop the candidate's capacity as an independent clinician-scientist focused on emergency medical services (EMS)-based interventions for substance use disorders (SUD)....
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Columbia University a $1.51M Project Grant (CFDA 93.279: Drug Use and Addiction Research Programs) on August 15, 2025, to develop and pilot an integrated HIV/Overdose Education and Naloxone Distribution (OEND) peer navigation intervention targeting Latinx people who use and sell drugs (PWUSD) in Kensington, Philadelphia. The R34 pilot study will train 45 PWUSD in naloxone use and distribution while linking...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded UC San Diego a Project Grant totaling $439,500 under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning March 1, 2026, with completion targeted for February 29, 2028. This grant supports the development of a novel research paradigm for collecting real-time, intensive longitudinal data on family dynamics and their relationship to adolescent substance use. The primary deliverable involves establishing...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Oklahoma State University Center for Health Sciences a $377,586 Project Grant on February 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct research on sex-specific sumoylation mechanisms in heroin-seeking behavior. The research will examine how post-translational protein modifications mediated by the enzyme UBC9 influence heroin addiction and neuroadaptations differently in...
- Federal Project Grant Award Summary Tufts University School of Medicine received a $386,500 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) on September 15, 2025, with completion scheduled for August 31, 2027. This R21 exploratory grant funds fundamental neuroscience research investigating the neurobehavioral consequences of fentanyl overdose and their relationship to relapse risk in individuals with opioid use...
- Federal Grant Award Summary The University of Alabama at Birmingham received a $894,000 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) effective April 1, 2026, through March 31, 2028. This award supports a Type 1 Hybrid Effectiveness-Implementation randomized controlled trial (RCT) addressing the U.S. opioid crisis by developing and testing a remote fentanyl test strip (FTS) distribution and education intervention. The...
- Federal Grant Award Summary American University received a $476,496 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning August 15, 2025, and concluding July 31, 2028. The grant funds fundamental neuroscience research investigating opioid signaling mechanisms in reward-guided decision-making within the rat prefrontal cortex, specifically the prelimbic area. The research employs a two-alternative forced choice...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Pennsylvania State University a $1.68 million Project Grant effective August 1, 2025, through May 31, 2030, under the Drug Use and Addiction Research Programs (CFDA 93.279). This longitudinal research initiative examines developmental cascades linking prenatal and postnatal substance exposure and maternal psychological distress to adolescent risk behaviors, with particular emphasis on parent-child interpersonal...
- Federal Grant Award Summary The National Institute on Drug Abuse awarded the University of Cincinnati a Project Grant totaling $1,723,975 on July 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct translational research on single-cell opioid and fentanyl responses in the context of HIV infection. The research employs a multi-omics approach combining in vivo and ex vivo studies to evaluate the impact of fentanyl on peripheral blood mononuclear cell (PBMC)...
Arizona State University received a $193,958 Project Grant awarded May 15, 2026, by the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a mixed-methods, community-engaged research study examining the role of family and household members in reducing fatal opioid overdose deaths. The research will identify household and family characteristics associated with overdose risk and protective factors, while also examining how community-level factors moderate these associations. A key component of the research involves developing and evaluating culturally adapted Overdose Education and Naloxone Distribution (OEND) programs specifically targeted to Hispanic family members and individuals at risk of overdose, addressing documented disparities in naloxone access and training among Hispanic populations. The project, which extends through April 30, 2031, will produce evidence-based knowledge on family-level interventions for overdose prevention and deliver culturally tailored OEND program materials and implementation frameworks. By positioning household members as first responders equipped with overdose recognition and naloxone administration skills, the research aims to address the gap between the established effectiveness of OEND programs and their underutilization among Hispanic communities. This work directly supports NIDA's priority to develop new prevention approaches and implementation science strategies for reducing drug overdose mortality in underserved populations.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $194.0k | 5/13/26 |